产品详情
简单介绍:
重组鼠皮肤T细胞吸引趋化因子/ CCL27蛋白与其它公司提供的重组蛋白不同,rMuCTACK/CCL27蛋白产品为采用CFS的无细胞麦胚蛋白合成系统表达出来的重组蛋白,可表达出对细胞有毒性、易被蛋白酶降解的蛋白;并获得具有良好的可溶性,并有翻译后修饰、从而部分具有功能的蛋白.同时独有的全自动蛋白纯化技术则简便高效,将蛋白纯化过程中对蛋白的损伤降低到*小程度.重组鼠皮肤T细胞吸引趋化因子/ CCL27蛋白(全长序列)产品可用于Western Blot验证、抗体制备、蛋白检测、ELISA等试验中.
详情介绍:
重组鼠皮肤T细胞吸引趋化因子/ CCL27蛋白
Species | Murine |
Accession | Q9Z1X0 |
GeneID | 20301 |
Source | Escherichia coli. |
Molecular Weight | 重组鼠皮肤T细胞吸引趋化因子/ CCL27蛋白Approximately 10.9 kDa, a single, non-glycosylated polypeptide chain containing 95 amino acids. |
Quantity | 5µg/20µg/1000µg |
AA Sequence | LPLPSSTSCC TQLYRQPLPS RLLRRIVHME LQEADGDCHL QAVVLHLARR SVCVHPQNRS LARWLERQGK RLQGTVPSLN LVLQKKMYSN PQQQN |
Purity | > 98 % by SDS-PAGE and HPLC analyses. |
Biological Activity | 重组鼠皮肤T细胞吸引趋化因子/ CCL27蛋白Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human peripheral blood lymphocytes is in a concentration range of 10-100 ng/ml. |
Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation | Lyophilized from a 0.2 µm filtered concentrated solution in 2 × PBS, pH 7.4, with 5% trehalose. |
Endotoxin | 重组鼠皮肤T细胞吸引趋化因子/ CCL27蛋白Less than 1 EU/µg of rMuCTACK/CCL27 as determined by LAL method. |
Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
Storage | This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles. |
重组鼠皮肤T细胞吸引趋化因子/ CCL27蛋白 | |
SDS-PAGE |